首页> 美国卫生研究院文献>Springer Open Choice >Sepsis: A Review of Advances in Management
【2h】

Sepsis: A Review of Advances in Management

机译:败血症:管理学进展回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Infections represent a common health problem in people of all ages. Usually, the response given to them is appropriate and so little treatment is needed. Sometimes, however, the response to the infection is inadequate and may lead to organ dysfunction; this is the condition known as sepsis. Sepsis can be caused by bacteria, fungi or viruses and at present there is no specific treatment; its management basically focuses on containing the infection through source control and antibiotics plus organ function support. This article reviews key elements of sepsis management, focusing on diagnosis, biomarkers and therapy. The main recent advance in therapy is the strategy of personalized medicine, based on a precise approach using biomarkers to identify specific individuals who are likely to benefit from more personalized attention.
机译:感染代表了各个年龄段的人的常见健康问题。通常,给予他们的反应是适当的,因此几乎不需要治疗。但是,有时对感染的反应不充分,可能导致器官功能障碍。这就是所谓的败血症。败血症可能是由细菌,真菌或病毒引起的,目前尚无特效治疗方法。它的管理主要集中在通过源控制和抗生素以及器官功能支持来控制感染。本文回顾了败血症管理的关键要素,重点是诊断,生物标志物和治疗。最近的主要治疗进展是个性化医学的策略,该策略基于使用生物标记物识别可能受益于更多个性化关注的特定个体的精确方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号